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Purpose: Acute mesenteric schemia (AMI) is a morbid condition with a difficult diagnosis and a high rate of compli- 
cations, which is associated with a high mortality rate. For the evaluation of the results of current management and the 
examination of factors associated with survival, we reviewed our experience. 
Methods: The clinical data of all the patients who underwent operation for AMI between January 1, 1990, and 
December 31, 1999, were retrospectively reviewed, clinical outcome was recorded, and factors associated with survival 
rate were analyzed. 
Results: Fifty-eight patients (22 men and 36 women; mean age, 67 years; age range, 35 to 96 years) underwent study. 
The cause of AMI was embolism in 16 patients (28%), thrombosis in 37 patients (64%), and nonocclusive mesenteric 
ischemia (NMI) in five patients (8.6%). Abdominal pain was the most frequent presenting symptom (95%). Twenty- 
five patients (43%) had previous symptoms of chronic mesenteric ischemia. All the patients underwent abdominal 
exploration, preceded with arteriography in 47 (81%) and with endovascular treatment in eight. Open mesenteric revas- 
cularization was performed in 43 patients (bypass grafting, n = 22; thromboemboiectomy, n = 19; patch angioplasty, 
n = 11; endarterectomy, n = 5; reimplantation,  = 2). Thirty-one patients (53%) needed bowel resection at the first 
operation. Twenty-three patients underwent second-look procedures, 11 patients underwent bowel resections (repeat 
resection, n = 9), and three patients underwent exploration only. The 30-day mortality rate was 32%. The rate was 31% 
in patients with embolism, 32% in patients with thrombosis, and 80% in patients with NMI. Multiorgan failure (n = 
18 patients) was the most frequent cause of death. The cumulative survival rates at 90 days, at 1 year, and at 3 years 
were 59%, 43%, and 32%, respectively, which was lower than the rate of a Midwestern white control population (P < 
.001 ). Six of the 16 late deaths (38%) occurred because of complications of mesenteric schemia. Age less than 60 years 
(P < .003) and bowel resection (P = .03) were associated with improved survival rates. 
Conclusion: The contemporary management of AMI with revascularization with open surgical techniques, resection of 
nonviable bowel, and liberal use of second-look procedures results in the early survival of two thirds of the patients 
with embolism and thrombosis. Older patients, those who did not undergo bowel resection, and those with NMI  have 
the highest mortality rates. The long-term survival rate remains dismal. Timely revascularization in patients who are 
symptomatic with chronic mesenteric schemia should be considered to decrease the high mortality rate ofAMI.  (J Vasc 
Surg 2002;35:445-52.) 
Acute mesenteric ischemia (AMI)  is an uncommon 
condition. It  can occur as a result of  acute arterial throm- 
bosis, usually as a complication of underlying atheroscle- 
rosis, or, less frequently, because ofarterit is,  f ibromuscular 
dysplasia, dissection, trauma, or mesenteric aneurysm rup- 
ture.k2 In mesentcric embolism, the mbolus originates 
from the left ventricle, from the lef~ atrium, or, less fre- 
quently, from the thoracic or upper abdominal  aorta, a 6 
Nonocclusive mesenteric ischemia (NMI )  develops as a 
result of hypoperfusion caused by a low cardiac output  or 
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mesenteric arterial spasm. 7-9 Ischemic colitis is a separate 
clinical entity that usually develops as the result of  throm- 
bosis or low flow in the inferior mesenteric artery or 
hypogastric irculation. 1° Finally, AMI may also develop 
because of  acute mesenteric venous thrombosis. 11 
AMI  affects predominant ly  the circulation to the 
midgut, hnpai rments  of  the arterial circulation because of 
thrombosis, embolism, or nonocclusive ischemia are mor- 
bid conditions and have a difficult diagnosis. The overall 
mortal i ty rate in reported series averaged 69% (Table 
I). 2,5,6,I2-32 For the evaluation of  the results o fcontempo-  
ra W management  and for the examination of  fhctors asso- 
ciated with survival, we reviewed our experience. 
PAT IENTS AND METHODS 
The clinic records of  all the patients who underwent  
surgical treatment lbr AMI because of  embolism, throm- 
bosis, and NMI  between January 1, 1990, and December 
31, 1999, were retrospectively reviewed. The demographic 
information,  comorb id  medical condit ions, history and 
physical examination findings, laboratory test results and 
records of  the radiologic examinations (arteriography, 
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Table I. Published series of  acute mesenteric ischemia 
First author Publication year No. of patients Mortali U rate 
Foley 2000 21 24% 
Mamode 1999 57 81% 
Newman 1998 98 60% 
Urayama 1998 34 35% 
Klempnauer 1997 90 66% 
Voltolini 1996 47 72% 
Konturek 1996 28 96% 
Ward 1995 34 45% 
Deehan 1995 43 70% 
Levy 1990 62 40% 
Batellier 1990 65 51% 
Bapat 1990 20 40% 
Finucane 1989 32 69% 
Sitges-Serra 1988 83 71% 
Wilson 1987 102 92% 
Lazaro 1986 23 27% 
Andersson 1984 60 82% 
Sachs 1982 30 77% 
Krausz 1978 40 78% 
Kairaluoma 1977 44 70% 
Boley 1977 30 46% 
Smith 1976 23 91% 
Singh 1975 32 81% 
Ottinger 1967 136 92% 
Total 1234 69% 
computed tomography [CT],  duplex scanning), and 
endovascular procedures were abstracted. The data from 
operative records, postoperative complications, mortality, 
and hospital stay were recorded. The results of any fbllow- 
up imaging study were noted, and the patency of  the revas- 
cularization or the earliest date of  symptom recurrence or 
mesenteric vascular disease recurrence were also recorded. 
The long-term follow-up intbrmation was obtained from 
the clinical records and from telephone interviews. The fac- 
tors associated with survival were analyzed. Cause of  death 
was determined from clinic records, autopsy findings, and 
death certificates. This study was approved by the 
Institutional Review Board of  the Mayo Foundation. 
For statistical analysis, the associations between peri- 
operative mortality rate and risk factors were assessed uni- 
variately with two-sample t test, Wilcoxon rank sum test, 
and % 2 test or Fisher exact test. The survival rate was esti- 
mated with the Kaplan-Meier method. Comparisons of  
survival curves were made with the log-rank test. A multi- 
variate Cox proportional hazards model was constructed 
with factors found to be significantly associated with sur- 
vival rate on univariate analysis results. All the tests were 
two-tailed. The test results were considered significant at 
a P value of  less than .05. 
RESULTS 
Demograph ic  data and risk factors. From January 
1, 1990, to December 31, 1999, 58 patients underwent 
surgical intervention for AMI  at the Mayo Clinic in 
Rochester, Minn. There were 36 women and 22 men 
(mean age, 67 years; range, 35 to 96 years). The cause of  
AMI was embolism in 16 patients (28%), thrombosis in 37 
patients (64%), and NMI  in five patients (9%). The 
patients with embolism, in comparison with the patients 
with thrombosis, were older (74 versus 63 years; P = 
.0027) and had a higher percentage of atrial fibrillation 
(50% versus 11%; P = .002; Table II). Only two of the 
eight patients in the embolism group with atrial fibrillation 
were undergoing long-term anticoagulation therapy at 
presentation. Atherosclerosis was highly prevalent, and 
64% of the patients had disease in two or more of the vas- 
cular distributions (Table II). 
The thrombosis group had a higher incidence rate of 
chronic mesenteric ischemia symptoms than did the 
embolism group (65% versus 6%; P = .001; Table II). The 
mean duration of  symptoms before the acute presentation 
was 8.2 months (median, 5.5 months). Fifteen patients 
(26%) had AMI  within 6 weeks after a cardiac (n = 4 
patients) or vascular operation (aortic, n = 3 patients; 
mescnteric, n = 3 patients; peripheral vascular procedures, 
n = 2 patients). Prior mesenteric reconstruction was per- 
tbrmcd in eight patients. 
Clinical presentation. Fifty-five patients (95%) were 
seen with acute abdominal pain for a median of  24 hours 
duration and were available for preoperative valuation 
(Appendix A, online only). Three patients were seen with 
shock with worsening acidosis and were taken immediately 
to the operating room for exploration. Nausea was the 
second most frequent symptom (44%), followed by vom- 
iting and diarrhea (35% each). Sixteen percent of  the 
patients had blood per rectum. The mean leukocyte count 
was elevated at 20.3 x 109/mL; the count was abnormal 
in 98% of the tested patients and was more than 20 x 
109/mL in 50%. Lactate level was elevated in 91% of all 
the tested patients and was more than 3 mmol /L  in 61% 
(Appendix B, online only). 
D iagnost ic  evaluat ion.  Aortography and selective 
mesenteric arteriography, if possible, were pcrfbrmed in 
49 patients (84%), and results confirmed mesenteric arte- 
rial occlusive disease in all the cases (Appendix C, online 
only). A distinction between embolism and thrombosis 
could not always be made befbre surgery. Embolism was 
identified in 11 of  the 13 studies (77%) and thrombosis in 
33 of  the 34 studies (97%). Arteriographic results con- 
firmed occlusion of a previously placed graft in eight of  
eight studies (100%). Arteriography was used in the iden- 
tification of  NMI  in two of  five patients. 
CT scanning was perfbrmed in 18 patients, and results 
confirmed superior mesenteric artery occlusion in 14 
patients (78%; Appendix C, online only). Findings sugges- 
tive of  bowel ischemia, including pncumatosis intestinalis, 
bowel wall thickening, ileus, and bowel dilatation, were 
seen in 11 patients (61%). Overall, 16 of  the 18 CT scans 
(89%) had positive results that confirmed either arterial 
occlusion or bowel changes compatible with AMI. Duplex 
scan evaluation was performed in three patients, and 
results confirmed mesenteric vessel occlusion in two. 
Endovascular  t reatment.  Eight patients underwent 
initial endovascular treatment. Six patients underwent 
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Table I I .  Patient demographics, group characteristics, and medical conditions 
Condition EMB THR NMI Total 95% CI 
No. of patients 16 (28%) 37 (63%) 5 (9%) 58 
Age (mean; years) 74 63 69 67 
No. of female patients 10 22 4 36 (62%) 52% - 78% 
No. of male patients 6 15 1 22 (38%) 26% - 52% 
Hypertension 14 (88%) 26 (70%) 5 (100%) 45 (78%) 65% - 87% 
Tobacco 8 (50%) 28 (76%) 5 (100%1) 41 (71%) 57% - 82% 
Family history of cardiovascular disease 8 (50%) 28 (76%) 4 (80%) 40 (69%) 55% - 80% 
Peripheral vascular disease 11 ('69%) 21 (57%) 4 (80%) 36 (62%) 48% 74% 
Coronary artery diseasc 9 (56%) 16 (43%) 4 (80%) 29 (50%) 37% - 63% 
Chronic mcsenteric schemia symptoms 1 (6%) 24 (65%) 0 (0%) 25 (43%) 30% 57% 
Recent surgery 3 (,19%) 10(27%) 3 (60%) 16 (28%) 15% - 39% 
Diabetes 4 (25%) 12 (32%) 1 (20%) 17 (29%) 18% 43% 
Congestive heart failure 8 (50%) 7 (19%) 2 (40%) 17 (129%) 18% - 43% 
Renal insufficiency 7 (44%) 9 (24%) 2 (40%) 18 (31%) 20% - 45% 
Prior myocardial infarction 4 (25%) 7 (19%) 3 (60%) 14 (24%) 14% 37% 
Ccrebrovascular disease 4 (25%) 9 (24%) 1 (20%) 14 (24%) 14% - 37% 
Chronic obstructive pulmonary disease 4 (25%) 8 (22%) 2 (40%) 14 (24%) 14% 37% 
Digoxin use 7 (44%) 6 (16%) 1 (20%) 14 (24%) 14% - 37% 
Hypercholesterolemia 4 (25%) 6 (16%) 2 (40%) 12 (21%) 11% 33% 
Atrial fibrillation 8 (50%) 4 (i1%) 0 (0%1) i2 (,21%) 1 i% - 33% 
EMB, Embolism; THR, thrombosis; NMI, nonocclusivc mesenteric is hcmia; C1, confidence interval. 
transcatheter vasodilator therapy, onc patient underwcnt 
percutaneous balloon angioplasty, and catheter-directed 
thrombolysis was attempted in another patient. This last 
patient subsequently needed laparotomy, embolectomy 
with patch angioplasty, and bowel resection. Second-look 
procedure showed healthy bowel. Among the six patients 
who underwent transcatheter vasodilator therapy, all 
underwent subsequent laparotomy, five needed surgical 
revascularization, and four had bowel resection. Six of  
these eight patients died within 30 days. 
Surgical treatment. All 58 patients underwent surgi- 
cal exploration (Table III). Mesenteric revascularization was 
perfbrmed in 43 patients (bypass grafting, n = 22; throm- 
boembolectomy, n = 19; patch angioplasty, n = 11; 
endarterectomy, n = 5; reimplantation, n = 2). Twenty- 
three patients (40%,) underwent second-look procedures. 
Bypass grafting was per~brmed in 22 patients with throm- 
bosis with polyester grafts in 17 patients (straight, n = 7; 
bifurcated, n = 10) and vein in five patients (straight, n = 4; 
bifurcated pantaloon graft, n = 1 ). The supraceliac aorta was 
used in 15 patients (celiac artery alone, n = 1; mesenteric 
alone, n = 5; celiac/hepatic and mesenteric, n = 9), and the 
inffarcnal aorta was used in seven patients (all mesenteric). 
Thirty-one patients underwent bowel resection during 
the first procedure. O f  the 23 second-look procedures, 11 
patients had bowel resections (further resection, n = 9; 
resection at second-look only, n = 2). Thirty-three patients 
underwent bowel resections at first-look or second-look 
laparotomy, and 16 of  these patients had ostomies. 
Morb id i ty  rate. Major complications were frequent 
and occurred in 46 patients (79%; Appendix D, online 
only). Patients had a mean of  4.1 complications. 
Respiratory failure (36%) and multiorgan failure (31%) 
were the most frequent complications. Fifteen patients 
had suspected or known recurrent bowel infarction in the 
early postopcrative period. Although seven patients under- 
went emergcncy bowel resection, eight additional patients 
received only supportive care for suspected or known 
recurrent boa,el ischemia nd a nonsalvagcable condition. 
Only three of  thcse 15 survived, and all the survivors 
underwent bowel rcsection. Reocclusion of  the mesenteric 
arteries was documented in fbur patients and resulted in 
death in two patients. Three additional patients had 
embolism elsewhere: two to the lower limbs and one with 
diffusc mesenteric and systemic atheroembolism. There 
were seven myocardial infarctions, and 13 cardiac arrests. 
Eleven patients became ventilator-dependent. There was 
renal failure in nine patients (one patient needed dialysis), 
hepatic failure in nine patients, and two strokes. 
Gastrointestinal hemorrhage occurred in 12 patients. 
Early morta l i ty  rate. The 30-day mortality rate was 
32% (98% confidence interval [CI], 15% to 46%). The rate 
was 31% (98% CI, 4% to 51%) in patients with embolism, 
32% (95% CI, 15% to 46%) in patients with thrombosis, 
and 80% (95% CI, 0 to 96%) in patients with NMI  
(embolism versus thrombosis, P value was not significant; 
embolism or thrombosis versus NMI ,  P < .001 ). Twenty 
four patients died within 90 days (41%; 95% CI, 27% to 
53%), and 23 patients died while still in the hospital. The 
causes of  early death included multiorgan fhilure in 18 
patients, mesenteric ischemia s the result ofrethrombosis 
in two patients, myocardial infarction in two patients, 
chronic obstructive pulmonary disease in one patient, and 
unknown cause in one patient. Mesenteric ischemia con- 
tributcd to multisystem organ failure in 12 of  18 patients 
(67%; Table IV). The patients who died were older (mean 
age, 72 versus 63 years; P = .03). Age greater than or 
equal to 60 years resulted in a 84'% mortality rate as com- 
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Table I I I .  Procedures 
EMB THR NMI  Total 
Thromboembolectomy 12 (75%) 7 (19%) 0 19 
Patch angioplasty 6 (38%) 5 (14%) 0 11 
Endarterectomy 0 5 (14%) 0 5 
Reimplantation f SMA into aorta 0 2 (5 % ) 0 2 
Bypass graft 0 22 (59%) 0 22 
Vein 0 5 (23%) 0 5 
Polyester 0 17 (77%) 0 17 
Antegrade 0 15 (68%) 0 15 
Retrograde 0 7 (32%) 0 7 
Single 0 12 (55%) 0 12 
Double 0 10 (45%) 0 10 
Resection 
Of small bowel 5 (31%) 13 (35%) 2 (40%) 20 
Of large bowel 0 2 (5%) 0 2 
Of small and large bowel 5 (31%) 3 (8%) 1 (20%) 9 
Second-look procedure 9 (56%) 12 (36%) 2 (40%) 23 
Resection of bowel (any) 5 (31%) 6 (16%) 0 11 
Resection of small bowel 3 (30%) 6 (40%) 0 9 
Resection of large bowel 1 ( 10% ) 0 0 1 
Resection of small and large bowel 1 (10%) 0 0 1 
EMB, Embolism; THR, thrombosis; NMI, nonocclusive mesenteric ischemia; SMA, superior mesenteric artery. 
Table IV. Causes of early and late mortality 
Mortality No. of deaths 
At <90 days 
Multiorgan failure/sepsis 18 (75%) 
Mesenteric thrombosis 2 (8%) 
Myocardial infarction 2 (8%) 
Coronary obstructive pulmonary disease 1 (4%) 
Unknown 1 (4%) 
Total 24 
At >90 days 
Cardiac 4 (25%) 
Short bowel syndrome 3 (19%) 
Mesenteric ischemia 2 ( 13 %) 
Cancer 2 (13%) 
Unknown 2 ( 13 %) 
Pulmonary embolus 1 (6%) 
Chronic obstructive pulmonary disease 1 (6%) 
TPN line sepsis 1 (6%) 
Total 16 
pared with a rate of 12% for those patients who were 
younger than 60 years (P = .003). Age greater than or 
equal to 70 years was related to a 39% mortality rate as 
compared with a 26% rate for patients who were younger 
than 70 years (P = .01 ). Gender, revascularization, chronic 
mesenteric ischemia symptoms, and cardiovascular risk 
factors were not associated with early death. Having AMI 
as a complication of another surgery performed within 43 
days was associated with increased mortality rate at 90 
days (66% versus 36%; P = .03). 
Late results. The mean follow-up period was 529 
days (range, 0 to 2877 days) and was complete. Recurrent 
symptoms occurred in 10 patients and included abdomi- 
nal pain in six, diarrhea in five, and nausea nd vomiting in 
two. Five patients had short bowel syndrome, and all were 
on long-term total parenteral nutrition (TPN). At last fol- 
low-up examination, 10 patients had weight gain (mean, 
20 lbs), 12 had unchanged weights, and seven had weight 
loss (mean, 17 lbs). Fol low-up imaging studies were 
obtained for 11 of 16 patients with prosthetic grafts 
(duplex scan, n = 5; arteriography, n = 3; CT scan, 2; mag- 
netic resonance angiography, n = 1). Patency was demon- 
strated in nine grafts to a mean of 1.4 years. Two graft 
occlusions occurred at 21 and 136 days, and both were 
associated with recurrent mesenteric ischemia. One 
patient underwent surgical thrombectomy of the occluded 
bypass graft, and the other patient underwent percuta- 
neous angioplasty. Both patients had symptom resolution. 
One patient died 1.5 years later of TPN line sepsis, and the 
other, also 1.5 years later, died of a cardiac arrhythmia. 
Two additional patients had superior mesenteric artery 
occlusive disease develop. Both refused reoperation, and 
both died at 131 and 176 days after symptom recurrence 
(Table IV). 
The overall survival rate (Fig 1) was 59% (95% CI, 47% 
to 73%) at 90 days, 43% (95% CI, 32% to 58%) at 1 year, 
and 32% (95% CI, 21% to 48%) at 3 years, which was sig- 
nificantly less than the rate for a white Midwestern control 
population (P < .001). The median survival time for all 
patients was 238 days. Survival analysis results by groups 
(Fig 2) showed significantly worse survival rate in the 
NMI group as compared with e rates in the embolism or 
thrombosis groups (P < .001). Six of 16 late deaths (38%) 
were attributable to mesenteric schemia (Table V). 
Factors associated w i th  survival  rate. Univariate 
analysis results for factors associated with improved sur- 
vival rate are listed in Table V. The significant factors 
include age less than 60 years, bowel resection at first-look 
or second-look procedure, and no recent major cardiovas- 
cular surgery. Approaching significance was bowel resec- 
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tion at first operation (P = .056), performance of arteri- 
ography (P = .074), and time to presentation greater than 
or equal to 24 hours (P = .085). When the association of  
time greater than 24 hours and bowel resection at first 
operation was analyzed, the results showed improved sur- 
vival rate (P = .03). Survival rate was not significantly dif- 
ferent whether the bypass graft was antegrade (n = 15 
patients) or retrograde (n = 7 patients) or single (n = 12 
patients) or double (n = 10 patients; P value not signifi- 
cant for all). No statistically significant association with 
improved survival rate was found with chronic mesenteric 
ischemia symptoms, second-look procedures, cardiac risk 
factors, and comorbid medical conditions• 
Variables found to be univariately associated with sur- 
vival rate (age >60 years, recent surgery, bowel resection at 
first or second procedure) were entered into a multivariate 
analysis, and each was found to be independently associ- 
ated with survival rate (Table VI). Age older than 60 years 
increased mortality rate with a relative risk ratio of  3.0 
(95% CI, 1.3 to 6.9; P = .009). Recent surgery increased 
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Table V. Factors associated with survival rate with univariate analysis 
Survival rate (95% CI) 
Variable At  30 days At  1 year At  3 years P value 
Age less than 60 years 
Yes 88% (74% - 100%) 
No 54% (40% - 71%) 
Bowel resection at first-look or 
second-look procedure 
Yes 68% (54% - 85%) 
No 58% (43% - 82%) 
Recent major cardiovascular procedure 
Yes 43% (23% - 79%) 
No 69% (56% 85%) 
Bowel resection at first operation 
Yes 66% (51% - 84%) 
No 62% (45% - 83%) 
Artcriography 
Yes 68% (56% - 83%) 
No 46% (24% - 87%) 
Time to presentation _>24 h 
Yes 68% (54% - 85%) 
No 56% (37% - 87%) 
77% (58%-100%) 55% (33%-88%) .0027 
29% (18%-47%) 23% (13%-41%) 
53% (39%-73%) 46% (30%-67%) .03 
28%(14%-54%) 12%(4%-40%) 
21% (8% -58%) 21% (8%- 58%) .03 
50% (37% -68%) 36% (23%-55%) 
53% (41% -76%) 46%(29%-67%) .056 
29% (16% -54%) 13% (4% -42%) 
47% (34%-63%) 36% (23% -54%) .074 
27% (10% 72%) 18% (4%-64%) 
50% (36%-70%) 40% (26%-61%) .085 
31% (15%-65%) 12% (22%-62%) 
CI, Confidence interval. 
Table VI.  Variables independently associated with wors- 
ened survival rate with multivariate analysis 
Variable Relative risk ratio (95% CI) P va&e 
Age >60 years 3.0 ( 1.3 - 6.9) .0093 
Bowel resection at first-look 0.5 (0.2 - 0.9) .0182 
or second-look procedure 
Previous surgery 2.4 ( 1.2 - 4.9) .0229 
P values determined with X 2 test. 
CI, Confidence interval. 
the relative risk of  mortality rate 2.4 times (95% CI, 1.2 to 
4.9). Bowel resection at first-look or second-look proce- 
dure decreased mortality rate with a relative risk ratio of  
0.5 (95% CI, 0.2 to 0.9). 
DISCUSSION 
AMI  remains a morbid condit ion with poor short- 
term and long-term survival rates. Although no popula- 
tion-based ata have been published, the incidence rate of" 
this lethal condition is increasing. In 1967 in an autopsy 
series, Ottinger and Austen 32 reported a rate of  8.8 cases 
of  AMI per 10,000 hospital admission. Almost 30 years 
later, Stoney and Cunningham 33 observed an incidence 
rate of  i in 1000 hospital admissions. As the mean age of 
the population increases and the proport ion of  older 
patients in our hospitals grows, AMI will predictably be 
more common. Unfortunately, as reported in other series 
as well, mortality rate in older patients is significantly 
greater and carries a relative risk of" mortality rate of  3.0 for 
those more than the age of  60 years. 
Early recognition of  AMI is crucial because irreversible 
bowel necrosis develops in many patients by the time of 
abdominal exploration. Fifty-seven percent of  our patients 
needed bowel resection at the time of the first operation, 
and no resection was perfbrmed because of  an unsalvage- 
able situation with excessive bowel necrosis in an addi- 
tional 5%. A high index of  clinical suspicion is needed, and 
our data concur with the classic teaching of  pain out of 
proportion to physical findings. Pain was present in 95% of 
our patients, but signs of  frank peritonitis were frequently 
late or absent. Abdominal distension and motility prob- 
lems, such as nausea, w)miting, or constipation, were 
more frequent. Laboratory abnormalities were present in 
98% of our patients, particularly lcukocytosis and high lac- 
tate levels. Unfi)rtunately, none of these findings is specific 
for AMI. CT scanning and contrast arteriography con- 
tinue to play a major role in the diagnosis of  AMI. 34 38 CT 
scanning has been reported to be sensitive in the diagno- 
sis of  mesenteric occlusion, 39,4° and our findings are in 
agreement. CT scan results confirmed mesenteric arterial 
occlusion or suggested ischemic bowel in 89% of  the 
patients studied. This imaging method also allows the 
identification of  nonvascular causes of  acute abdominal 
pain. CT scan with three-dimensional reconstruction is an 
increasingly useful technique, which may allow identifica- 
tion of  vascular anatomy and pathology with good enough 
detail for diagnosis and operative planning. 
Contrast arteriography plays an important role in early 
diagnosis and is helpful in planning and initiating treat- 
ment.29, 38 We fbund that arteriographic results confirmed 
mesenteric vascular disease in 100% of the cases and cor- 
rectly identified thrombosis or embolism in 94%. 
Endovascular interventions or catheter-directed vasodila- 
tor therapy can be started immediately after arteriography. 
The role of  endovascular therapy in AM1 continues to 
be limited and somewhat controversial. Boley and others 29 
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used arteriography and subsequent catheter based inter- 
ventions or transcatheter vasodilator therapy as the initial 
or sole therapy of AMI. In NMI, catheter-directed 
vasodilator infusion without peritonitis continues to be 
the treatment of choice and is the accepted treatment. 
Mortality rate in NMI continues to be excessive. Gallego 
and colleagues 41 and McBride and Gaines 42 have used 
catheter-directed thrombolysis with good results in the 
treatment of acute mesenteric embolism. Successful use of 
percutaneous angioplasty for AMI was reported by van 
Deinse and colleagues. 43
Undoubtedly, the number of endovascular interven- 
tions, angioplasty, and stenting for both acute and chronic 
mesenteric occlusive disease will increase in the future. In 
AMI, potential advantages include the chance to replace 
or decrease the need fbr open surgical reconstructions of 
the occluded arteries, performed not infrequently with 
prosthetic grafts in a potentially or de facto infected field. 
Our experience with catheter-based r constructions in 
AMI is limited, and only two patients had such treatment 
in this series, with good results in one. 
The goal of surgical care inAMI is the removal of non- 
saNageable bowel, the minimization and prevention of fur- 
ther bowel infarction, and the preservation of small 
intestinal length. The surgical procedure involves assess- 
ment of bowel viability, determination r confirmation of 
the underlying cause, revascularization, and resection of 
infarcted bowel. Second look procedures allow for the 
reassessment of bowel viability and further bowel resection 
as needed. Exploratory laparotomy (open or laparoscopic) 
remains the gold standard fbr the determination f bowel 
viability, and an operation is the only way to remove dead 
bowel. Bowel viability is assessed with physical examination 
(inspection, palpation), hand-held Doppler scan examina- 
tion, 44 and intravenous injection of fluorescein. 1°Absent, 
perivascular, or patchy fluorescein patterns are considered 
positive fbr impaired per fusion. Because ome of these per- 
fusion problems are reversible, the sensitivity and predictive 
value of positive test results at first operation do not negate 
the value of a second-look procedure. 45
The most useful surgical revascularization technique 
in embolism remains the balloon catheter thromboem- 
bolectomy, with or without patch angioplasty of the supe- 
rior mesenteric artery. Patients with chronic proximal 
occlusion or stenosis undergo revascularization with an 
aortomesenteric or, less ftequently, iliomesenteric bypass 
graft. Good results have been reported fbr both multives 
se146 and single-vessel reconstruction 12 in both the acute 
and chronic settings. Equally good results were obtained 
in this study when revascularization was performed t?om a 
supraceliac aortic origin or t?om a retrograde position, 
regardless of whether it was perfbrmed to one or two ves- 
sels. In AMI, most surgeons in our group favor single-ves- 
sel reconstruction now to the superior mesenteric artery, 
performed frequently in a retrograde fashion that is sim- 
pler to perform in the acute setting. In patients with bowel 
perfbration, a saphenous vein or rifampin-soaked polyester 
graft is our choice fbr conduit. 
Resection of the infarcted bowel is performed after 
revascularization. In our series, 48% of the patients needed 
an ostomy. Patients with bowel of questionable viability 
undergo a second-look procedure, usually within 24 
hours. The decision to reoperate is made during the first 
operation and is independent of the clinical status of the 
patient during the two procedures. The utility of second- 
look procedures was shown in other studies and in ours as 
well. Of our patients who underwent second-look proce- 
dures, 48% needed bowel resection. 
Resection of bowel in either first-look or secondqook 
procedures was associated with improved survival rate on 
univariate and multivariate analysis results and was associ- 
ated with a risk reduction of 0.5. Resectability may repre- 
sent a selection process of patients who had clearly 
demarcated necrotic and conversely remaining viable 
bowel, and the unresected group included both the non- 
salvageable cases (n = 3 patients) and patients whose con- 
ditions subsequendy eteriorated (n = 8 patients) but did 
not undergo peration (ie, resectability may be a marker 
tbr improved survival rate). There may also be a causal 
relationship between bowel resection and improved sur- 
vival rate, but this cannot be determined from these retro- 
spective data. 
Major postoperative complications remain excessive, 
and both early and late mortality rates continue to be 
high. Multiorgan failure is the most lethal complication, 
and it is thc rcsult of a combination of bowel ischemia, 
sepsis, and gencralizcd atherosclerosis because many 
patients are elderly with several cardiovascular risk factors. 
Recurrent and persistent mesenteric schemia remains a 
major threat o these patients and contributes significantly 
to the early and late mortality rates. Successful revascular 
ization, therefore, remains imperative and likely con 
tributes to the reduction of mortality rate to the 30% 
range in the embolism or thrombosis group from the 60% 
to 70% range reported earlier in several studies. Age less 
than 60 years and removal of the dead bowel were factors 
in our multivariate analysis that predicted improved sur- 
vival rate. 
Prevention of AMI may bc an cffectivc way to reduce 
the high mortality rate of this lethal disease. In some 
patients with underlying mesenteric athcrosclerosis, AMI 
could clearly be prevented with recognition and timely, 
elective revascularization f r symptoms of chronic mcsen 
teric occlusive discase, with much lower morbidity and 
mortality rates.12,46, 7 Almost half of the patients in our 
series had prior symptoms of chronic mesentcric schcmia. 
Our data also support reatment of atrial fibrillation with 
anticoagulation therapy. Seventy five percent of the 
patients with mesenteric cmbolism were not undergoing 
anticoagulation therapy with heparin or warfarin sodium 
at thc time of the ischemic event. 
In conclusion, contcmporary management of AMI 
should include a high index of clinical suspicion, rapid pre- 
operative valuation, revascularization with open surgical 
techniqucs, rcscction of nonviable bowcl, the liberal use of 
second-look procedures, ophisticated postoperative care 
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tbr the prevent ion o f  mul t iorgan failure, and the recogni- 
t ion o f  recurrent  mesenter ic  ischemia. A l though overall 
clinical outcome is still poor ,  such management  will result 
in the early survival o f  two thirds o f  the pat ients wi th  
embol ism and thrombosis .  Older patients, those who did 
not  undergo  bowel  resection, and those with NMI  have 
the h ighest  morta l i ty  rates. Long- term survival rate 
remains dismal because o f  the under ly ing cardiovascular 
disease and recurrent  mesenteric ischemia and shows how 
much needs to be done to prevent and treat this lethal dis- 
ease. T imely revascular izat ion o f  symptomat ic  pat ients 
wi th  chronic mesenter ic  occlusive disease could be one 
effective way to decrease the incidence and subsequent  
h igh mortal ity rates o f  AMI .  
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